FDC
Back to Income Statement
|
FDC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,108 Cr | ₹1,943 Cr | ₹1,784 Cr | ₹1,528 Cr | ₹1,333 Cr |
What is the latest Revenue of FDC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,108 Cr |
| Mar2024 | ₹1,943 Cr |
| Mar2023 | ₹1,784 Cr |
| Mar2022 | ₹1,528 Cr |
| Mar2021 | ₹1,333 Cr |
How is Revenue of FDC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,108 Cr | 8.50 | |
| Mar2024 | ₹1,943 Cr | 8.92 | |
| Mar2023 | ₹1,784 Cr | 16.74 | |
| Mar2022 | ₹1,528 Cr | 14.61 | |
| Mar2021 | ₹1,333 Cr | - | |
Compare Revenue of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,668.3 Cr | -0.1% | -6.4% | -15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -0.1% |
-6.4% |
-15.7% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses